News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
177,291 Results
Type
Article (8649)
Company Profile (63)
Press Release (168579)
Section
Business (55114)
Career Advice (96)
Deals (9722)
Drug Delivery (10)
Drug Development (29264)
Employer Resources (12)
FDA (4378)
Job Trends (4071)
News (97546)
Policy (7426)
Tag
Academia (395)
Alliances (17356)
Alzheimer's disease (197)
Antibody-drug conjugate (ADC) (64)
Approvals (4393)
Artificial intelligence (53)
Bankruptcy (61)
Best Places to Work (3592)
Biotechnology (56)
Bladder cancer (30)
Breast cancer (139)
Cancer (1021)
Career advice (83)
CAR-T (53)
Cell therapy (122)
Clinical research (24204)
Collaboration (224)
Compensation (57)
COVID-19 (470)
C-suite (46)
Data (590)
Diagnostics (1747)
Drug discovery (36)
Earnings (18808)
Events (28034)
Executive appointments (152)
FDA (4603)
Funding (125)
Gene therapy (39)
GLP-1 (127)
Government (647)
Healthcare (4840)
Infectious disease (488)
Inflammatory bowel disease (31)
IPO (4194)
Job creations (685)
Job search strategy (77)
Layoffs (118)
Legal (1346)
Liver cancer (43)
Lung cancer (171)
Lymphoma (56)
Manufacturing (46)
Medical device (1889)
Medtech (1890)
Mergers & acquisitions (5624)
Metabolic disorders (65)
Neuroscience (267)
NextGen Class of 2024 (1119)
Non-profit (543)
Northern California (579)
Obesity (30)
Ovarian cancer (37)
Pancreatic cancer (32)
Patents (27)
People (16459)
Phase I (8523)
Phase II (10263)
Phase III (8022)
Pipeline (216)
Postmarket research (657)
Preclinical (2758)
Prostate cancer (46)
Radiopharmaceuticals (169)
Rare diseases (55)
Real estate (1253)
Regulatory (5867)
Research institute (718)
Series A (33)
Southern California (488)
Startups (1088)
United States (4336)
Vaccines (115)
Date
Last 7 days (67)
Last 30 days (595)
Last 365 days (11500)
2025 (36)
2024 (11739)
2023 (13320)
2022 (18280)
2021 (18043)
2020 (15524)
2019 (11405)
2018 (8559)
2017 (9808)
2016 (8757)
2015 (10162)
2014 (7013)
2013 (5333)
2012 (5737)
2011 (5865)
2010 (5409)
Location
Africa (139)
Asia (26764)
Australia (3425)
California (1198)
Canada (444)
China (214)
Colorado (34)
Connecticut (49)
Delaware (61)
Europe (28969)
Florida (135)
Illinois (103)
Japan (63)
Maryland (189)
Massachusetts (1031)
Minnesota (75)
New Jersey (336)
New York (324)
North Carolina (158)
Northern California (579)
Ohio (31)
Pennsylvania (200)
South America (202)
Southern California (488)
Texas (174)
Utah (32)
Washington State (116)
177,291 Results for "redx oncology ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Jazz Pharmaceuticals Enters Definitive Agreement with Redx Pharma to Acquire Global Rights to KRAS Inhibitor Program
Jazz Pharmaceuticals plc and Redx Pharma plc announced that the companies have signed a definitive agreement under which Jazz will acquire Redx’s KRAS inhibitor program.
February 7, 2024
·
6 min read
Business
Jazz Inks Potential $880M Deal with Redx to Buy KRAS Inhibitors
Jazz Pharmaceuticals is acquiring Redx Pharma’s KRAS inhibitor program including preclinical-stage drug candidates, with the companies working to advance assets through IND-enabling studies.
February 7, 2024
·
2 min read
·
Tyler Patchen
Press Releases
Xenetic Biosciences, Inc. Enters into Clinical Trial Services Agreement with PeriNess Ltd. to Accelerate Development of DNase I Oncology Program
December 5, 2024
·
6 min read
Deals
Redx and Jounce Announce Recommended Business Combination
Redx Pharma and Jounce Therapeutics, Inc. announce an unanimously recommended Business Combination of the two companies via a proposed all share merger transaction.
February 23, 2023
·
19 min read
Press Releases
Portage Biotech Announces Letter of Intent with Immunova for an Option to Acquire iOx Therapeutics, Ltd
December 18, 2024
·
4 min read
Press Releases
AI/ML Innovations Closes Acquisition of Quantum Sciences Ltd.
December 24, 2024
·
8 min read
Press Releases
WORK Medical Technology Group LTD’s Subsidiary, Hangzhou Shanyou, Showcases Products at MEDICA Trade Fair 2024
November 28, 2024
·
4 min read
Press Releases
AI/ML Innovations to Acquire Quantum Sciences Ltd
December 10, 2024
·
4 min read
Deals
Jounce Slashes 57% of Staff, Drops Assets in Stock Merger with Redx
One day after revealing a restructuring initiative, Jounce Therapeutics announced it plans to merge its business in an all-stock deal with clinical-stage biotech Redx Pharma.
February 23, 2023
·
1 min read
·
Rosemary Scott
Pharm Country
Adlai Nortye Ltd. to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy (dCRT) at ASCO 2024
Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”) today announced that it will present encouraging preliminary data of AN0025 in combination with definitive chemoradiotherapy (dCRT) in unresectable locally advanced or locally recurrent esophageal cancer (EC) at the upcoming American Society of Cancer Oncology (ASCO) Annual Meeting to be held in Chicago from May 31 to June 4, 2024.
May 23, 2024
·
5 min read
1 of 17,730
Next
